-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
A company’s project has won the First Prize for Provincial Scientific and Technological Progress.
Category:
Time：2018-04-04
Recently, the Hebei Provincial Government announced the winners of the 2017 Provincial Science and Technology Awards. The company’s project, “Establishment and Application of a Quality Control System for Large-Volume Parenteral Solutions in Flexible Packaging,” was awarded the First Prize for Scientific and Technological Progress. It is the only enterprise in the province’s pharmaceutical manufacturing industry to receive this honor, marking a milestone in the company’s development in scientific and technological innovation. Ensuring the quality of parenteral solutions and safeguarding “safety at the tip of the needle” has long been the industry’s shared goal. Guided by this principle, the company has overcome one challenge after another with great determination and perseverance. Over the past 15 years, the company has refined its production processes for large-volume parenteral solutions in flexible packaging—from the preparation of pharmaceutical packaging materials, through filling, sealing, and final product inspection, to transportation and clinical application.
Recently, the Hebei Provincial Government announced the winners of the 2017 Provincial Science and Technology Awards. Our company’s project, “Establishment and Application of a Quality Control Technical System for Soft-Packaged Large-Volume Infusions,” was awarded the First Prize in the Science and Technology Progress Award. This is the only enterprise in the province’s pharmaceutical manufacturing industry to receive this honor, marking a milestone for our company in the field of scientific and technological innovation.
Ensuring the quality of intravenous infusion products and safeguarding “safety at the tip of the needle” have long been the industry’s shared goal. Guided by this mission, our company has overcome numerous challenges and breakthroughs one after another. Over the past 15 years, we have conducted systematic and in-depth research into every stage of soft-packaged large-volume infusion production—from pharmaceutical packaging material preparation and filling to sealing, finished-product inspection, transportation, and clinical use—ultimately achieving comprehensive process management, high-quality standards, environmental friendliness, and integrated innovation. As a result, our product quality and technological level have reached the leading domestic standard, earning the trust of medical institutions and patients both at home and abroad.
According to the introduction, during the research on this project, the company has obtained a total of 10 patents, formulated 10 national standards, established 4 national-level technical platforms, and achieved 4 original breakthroughs. Following review by industry experts, the quality control technology system for soft-packaged infusions developed under this project features significant innovative elements and remarkable clinical efficacy, reaching an internationally advanced level. These achievements have enriched the scientific content of the pharmaceutical industry and will play a tremendous role in driving the industry’s development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license